29 , 30 Moreover, very recent data from the randomized EXPIRA trial (Sardella, personal communication at TCT 2007 meeting) and the randomized TAPAS trial showed respectively a strong trend toward lower mortality at nine months 26 and a significantly lower mortality at 12 months in the group of patients treated with thrombectomy. 10 Therefore the available data support the possible advantage of thrombectomy on long-term clinical outcome.
← all excerpts
Individual patient-data meta-analysis comparing clinical outcome in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention with or without prior thrombectomy. ATTEMPT study: a pooled Analysis of Trials on ThrombEctomy in acute Myocardial infarction based on individual PatienT data.
1
—
—